Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Calcipotriol/Betamethasone |
Active Ingredients: | Betamethasone dipropionate 0.643mg/g equivalent to betamethasone base 0.500mg/g Calcipotriol 0.05mg/g |
Dosage Form: | Topical ointment |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | PLIVA Croatia Limited, Zagreb, Croatia |
Product: | Fynod |
Active Ingredients: | Fingolimod hydrochloride 0.56mg equivalent to fingolimod 0.5mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Viatris Limited |
Manufacturer: | Mylan Laboratories Limited, Pithampur, India |
Product: | Glucose 10% w/v |
Active Ingredient: | Glucose monohydrate 110g/L equivalent to glucose 100g/L |
Dosage Form: | Solution for infusion |
New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
Manufacturers: | Fresenius Kabi France, Louviers Cedex, France Fresenius Kabi AG, Friedberg, Germany |
Product: | Pabrinex |
Component 1: | |
Active Ingredients: | Pyridoxine hydrochloride 10mg/mL Riboflavin sodium phosphate 1.016mg/mL equivalent to riboflavin 0.8mg/mL Thiamine hydrochloride 50mg/mL |
Dosage Form: | Concentrate for infusion |
Component 2: | |
Active Ingredients: | Ascorbic acid 100mg/mL Glucose monohydrate 220mg/mL equivalent to glucose 200mg/mL Nicotinamide 32mg/mL |
Dosage Form: | Concentrate for infusion |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Haupt Pharma Wulfing GmbH, Gronau/Leine, Germany |
Product: | Paracetamol (GenericPharm) (General sale) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu’an Pharmaceutical Co Limited, Anqiu City, China |
Product: | Paracetamol (GenericPharm) (Pharmacy only) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu’an Pharmaceutical Co Limited, Anqiu City, China |
Product: | Paracetamol (MedPharm) (General sale) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu'an Pharmaceutical Co Limited, Anqiu City, China |
Product: | Paracetamol (MedPharm) (Pharmacy only) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu’an Pharmaceutical Co Limited, Anqiu City, China |
Product: | Paracetamol (MedPharm) (Prescription) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu’an Pharmaceutical Co Limited, Anqiu City, China |
Product: | Paracetamol (MedTech) (General sale) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu’an Pharmaceutical Co Limited, Anqiu City, China |
Product: | Paracetamol (MedTech) (Pharmacy only) |
Active Ingredient: | Paracetamol 500mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Ethos Consulting Group |
Manufacturer: | Anqiu Lu’an Pharmaceutical Co Limited, Anqiu City,China |
Product: | Vizo-PF Bimatoprost |
Active Ingredient: | Bimatoprost 0.3mg/mL |
Dosage Form: | Eye drops, solution |
New Zealand Sponsor: | AFT Pharmaceuticals Limited |
Manufacturers: | Excelvision, Annonay, France Ionisos, Sablé-sur-Sarthe, France |
Product: | Zematane |
Active Ingredient: | Alitretinoin 10mg |
Dosage Form: | Liquid filled capsule |
New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
Manufacturer: | Douglas Manufacturing Limited, Auckland, New Zealand |
Product: | Zematane |
Active Ingredient: | Alitretinoin 30mg |
Dosage Form: | Liquid filled capsule |
New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
Manufacturer: | Douglas Manufacturing Limited, Auckland, New Zealand |
Dated this 4th day of May 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).